Key statistics
On Friday, ProMIS Neurosciences Inc (PMN:NAQ) closed at 15.25, 143.22% above the 52 week low of 6.27 set on Nov 28, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 15.29 |
|---|---|
| High | 15.35 |
| Low | 14.99 |
| Bid | 15.01 |
| Offer | 15.95 |
| Previous close | 14.96 |
| Average volume | 76.31k |
|---|---|
| Shares outstanding | 2.15m |
| Free float | 1.62m |
| P/E (TTM) | -- |
| Market cap | 32.82m USD |
| EPS (TTM) | -18.62 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
- ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
- ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing
- ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease
- ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease
- ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk
- ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma pTau as a Predictive Early Endpoint in Alzheimer’s trials, Supporting its Ongoing Phase 1b PRECISE-AD trial with PMN310
- ProMIS Neurosciences to Participate in the 8th Annual Evercore Healthcare Conference
- ProMIS Neurosciences Announces Reverse Stock Split
- ProMIS Neurosciences Announces Third Quarter 2025 Financial Results & Corporate Highlights
- ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
More ▼
